VolitionRX Limited (VNRX) Financials
VNRX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 18.0 million | 20.9 million |
2023-06-30 | 27.6 million | 22.4 million |
2023-03-31 | 18.0 million | 21.0 million |
2022-12-31 | 18.3 million | 21.4 million |
VNRX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -8.7 million | 537980 |
2023-06-30 | -7.6 million | 592174 |
2023-03-31 | -8.9 million | 693657 |
2022-12-31 | -5.8 million | 706249 |
VNRX Net Income
No data available :(
VNRX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 10.8 million | - | 960398 |
2023-06-30 | 19.7 million | 2.5 million | 1.0 million |
2023-03-31 | 10.0 million | - | 1.1 million |
2022-12-31 | 10.9 million | 2.8 million | 1.1 million |
VNRX Shares Outstanding
VNRX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 273041 | 4.7 million | 3.9 million | 156775 |
2023-06-30 | 301394 | 5.5 million | 4.0 million | 254768 |
2023-03-31 | 200592 | 4.9 million | 4.0 million | 227985 |
2022-12-31 | 578752 | 4.0 million | 3.9 million | 272288 |
VNRX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 165211 | 362467 |
2023-06-30 | 216310 | 351668 |
2023-03-31 | 149808 | 334577 |
2022-12-31 | 119715 | 307834 |
VNRX
Price: $0.89
52 week price:
Earnings Per Share: -0.50 USD
P/E Ratio: -2.17
Exchange: ASE
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 202636
Market Capitalization: 58.8 million